Project cooperationUpdated on 21 January 2026
Human Collagen and Xeno-free Human ECM for Medical Applications
CEO at Arrakis Bio
Modi'in, Israel
About
Arrakis Bio developed a biomanufacturing platform for producing animal-free Human ECM and Human Collagen, based on human cells in a proprietary bio-reactor system that ensures consistent quality, reproducibility and scalability.
Application areas include - implantable medical devices, drug discovery platforms based on in-vitro NAMs, 3D bioprinting, Tissue regeneration (Bone, Skin, Tendon, Cartilage, etc), Cell therapy, drug delivery, and more.
Topic
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
3D-Bioprinted Scaffolds for Drug Delivery & Tissue Regeneration Partnership
- Consortium/Coordinator seeks Partners
- Partner seeks Consortium/Coordinator
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Sema Bayraktar
Research and Development Scientist at BlooCell
Istanbul, Türkiye
Project cooperation
Seeking Consortia & Expertise Offer for Tool-02 & Tool-03 (Bioprinting Projects)
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Hazal Evecen
Business Development Specialist at Galata Innovation
İstanbul, Türkiye
Project cooperation
Biotech looking for collaboration partners: Cell therapy and cell-derived products
- Partner seeks Consortium/Coordinator
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Moayed Hamza
CEO & Founder at HAON Life Science
Dublin, Ireland